Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-08-06 00:00:00 ET · period of report 2024-08-02 · accession 0001765581-24-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-06 | 2024-08-02 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | A - Grant | $0.00 | +6,996 | 24.1K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-08-02 | A | A | 6,996 | $0.00 | 24,078 | D | — | — | (F2) Includes 160 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan. |